| Code | 18670 | ||||||||||
| MA number | 42/0647/94-S | ||||||||||
| Product Form: | tbl flm 100x400 mg (fľ.PE) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | National | ||||||||||
| MAH, country: | MEDOCHEMIE Ltd., Cyprus | ||||||||||
| Therapeutic Class: | 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | container PE | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 26.10.1994 |
| Pediatric contraindication: | Yes |
| Pediatric warnings: | Yes |
| PIL: |
PIL_GYRABLOCK 400 mg_07.2025.pdf
|
| SPC: |
SPC_GYRABLOCK 400 mg_07.2025.pdf
|
| Safety feature | Yes |
| Data update: | 21.05.2018 |
